Evidence map›Paper›PMID 40256481›Full record

ArticleGland surgery2025

Development and validation of a semi-automatic radiomics ensemble model for preoperative evaluation of breast masses in mammotome-assisted minimally invasive resection.

Zhenfeng Huang, Qingqing Zhu, Yijie Li, Kunyi Wang, Yideng Zhang, Qiaowei Zhong, Yi Li, Qingan Zeng, Haihong Zhong

Abstract read
In one paragraph

Article in Gland surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Zhenfeng Huang *Department of Thyroid & Breast Surgery, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, China.
Qingqing Zhu *Department of Proctology, Wuhan Third Hospital, Tongren Hospital of Wuhan University, Wuhan, China.
Yijie Li *Department of Thyroid & Breast Surgery, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, China.
Kunyi WangDepartment of Thyroid & Breast Surgery, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, China.
Yideng ZhangDepartment of Thyroid & Breast Surgery, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, China.
Qiaowei ZhongZhuhai Campus of Zunyi Medical University, Zhuhai, China.
Yi LiDepartment of Thyroid & Breast Surgery, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, China.
Qingan ZengDepartment of Thyroid & Breast Surgery, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, China.
Haihong ZhongDepartment of Radiology, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Accurate preoperative differentiation of breast masses is critical for guiding individualized treatment strategies in Mammotome-assisted minimally invasive resection. While radiomics shows promise, existing methods rely on manual delineation, which is time-consuming and subjective. This study developed an ultrasound-based semi-automatic segmentation ensemble model to improve preoperative assessment. Methods: We retrospectively analyzed preoperative ultrasound images from 773 patients (543 tumors, 230 non-tumors). Semi-automatic segmentation was performed using DeepLabv3_ResNet50 and fully convolutional network (FCN)_ResNet50. Radiomic and deep transfer learning (DTL) features were extracted to construct radiomic, deep learning, and combined models. An ensemble strategy integrated these with clinical models. Performance was evaluated via receiver operating characteristic (ROC) curves and decision curve analysis (DCA). Results: The cohort included 543 tumor patients and 230 non-tumor patients (95 adenosis, 135 other benign lesions). The semi-automatic segmentation model, DeepLabv3_ResNet50, achieved a peak global accuracy of 99.4% and an average Dice coefficient of 92.0% at its best epoch. On the other hand, the FCN_ResNet50 model exhibited a peak global accuracy of 99.5% and an average Dice coefficient of 93.7% at its best epoch. In the task of predicting tumor and non-tumor patients, age, maximum diameter, and BI-RADS (Breast Imaging Reporting and Data System) classification were ultimately identified as key indicators, and the stacking model ultimately demonstrated an area under the curve (AUC) of 0.890 in the training cohort (with a sensitivity of 0.844 and a specificity of 0.815) and an AUC of 0.780 in the testing cohort (with a sensitivity of 0.713 and a specificity of 0.739). In the task of predicting adenosis and other lesion types, focus emerged as a crucial factor, and the stacking model achieved an AUC of 0.813 in the training cohort (with a sensitivity of 0.613 and a specificity of 0.859) and an AUC of 0.771 in the testing cohort (with a sensitivity of 0.759 and a specificity of 0.765). Conclusions: Our study has established an ensemble learning model grounded in semi-automatic segmentation techniques. This model accurately distinguishes between tumor and non-tumor patients preoperatively, as well as discriminating adenosis from other lesion types among the non-tumor cohort, thus providing valuable insights for individualized treatment planning. The proposed stacking model demonstrates significant clinical utility by reducing unnecessary biopsies and saving diagnostic time compared to manual review. These improvements directly address the challenges of overtreatment and diagnostic delays in breast lesion management. By enhancing preoperative accuracy, our model supports tailored surgical planning and alleviates patient anxiety associated with indeterminate diagnoses.

Indexed as

Breast lesiondeep learningmammotomeradiomicsultrasound (US)

Identifiers

PMID40256481
PMCPMC12004299

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.